StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / foresight-dx.com

Foresight Diagnostics

Foresight Diagnostics (foresight-dx.com): 2 changes recorded in its website history since June 2021. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeSee clearly. Act decisively.
    AfterBreakthrough cancer diagnostics. Next-level clinical outcomes.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. HeadlineBetween and
    BeforeSeeing more than ever before
    AfterSee clearly. Act decisively.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 2 June 2021

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

See more than ever before

The world’s most sensitive liquid biopsy minimal residual disease (MRD) test that detects the earliest hints of cancer relapse.

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. July 2025 – November 2026 · 4 captures · latest observed messagingBreakthrough cancer diagnostics. Next-level clinical outcomes.

    We develop innovative diagnostics to advance decision-making in oncology drug development and patient care.

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 4 captures in this group
    • 13 July 2025 · Breakthrough cancer diagnostics. Next-level clinical outcomes. archived page
    • 17 January 2026 · Breakthrough cancer diagnostics. Next-level clinical outcomes. archived page
    • 31 July 2026 · Breakthrough cancer diagnostics. Next-level clinical outcomes. archived page
    • 6 November 2026 · Breakthrough cancer diagnostics. Next-level clinical outcomes. current websiteHistorical capture not publicly available
  2. Seen July 2024 · 1 captureSee clearly. Act decisively.

    Foresight Diagnostics make the world’s most sensitive ctDNA/cfDNA liquid biopsy minimal residual disease (MRD) test that detects the earliest hints of cancer relapse.

    This wording observed 6 July 2024.

    archived page
  3. June 2021 – January 2024 · 6 capturesSeeing more than ever before

    Foresight Diagnostics make the world’s most sensitive ctDNA/cfDNA liquid biopsy minimal residual disease (MRD) test that detects the earliest hints of cancer relapse.

    This wording observed 2 January 2024.

    archived page
    Inspect 6 captures in this group

Cite this record

StartupHistory, “Foresight Diagnostics” company record, https://startuphistory.org/c/foresight-dx.com

Machine-readable: /c/foresight-dx.com.json. How changes are found: method.